Search Within

Jose T Baselga

  1. "Nancy Sklarin"
Formats
  1. Journal Article (8)
  2. Meeting Abstract (5)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (13)
  2. Breast Medicine Service (13)
  3. Department of Medicine (13)
  4. Solid Tumor Oncology Division (13)
  5. Survivorship Research (13)
  6. Behavioral Sciences Service (10)

More Groups

People
  1. Clifford Hudis (13)
  2. Nancy Sklarin (13)
  3. Larry Norton (12)
  4. Andrew Seidman (11)
  5. Teresa Gilewski (10)
  6. David Fennelly (9)

More People

Years
  1. 2015 (2)
  2. 1999 (2)
  3. 1998 (1)
  4. 1997 (1)
  5. 1996 (3)
  6. 1995 (3)

More Years

Publications
  1. Journal of Clinical Oncology (5)
  2. Breast Cancer Research and Treatment (2)
  3. Seminars in Oncology (2)
  4. Cancer Investigation (1)
  5. Clinical Cancer Research (1)
  6. European Journal of Cancer (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (5)
  2. Elsevier Inc. (3)
  3. American Association for Cancer Research (2)
  4. Springer (2)
  5. Informa Healthcare (1)

Results (13)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer (MBC): Updated progression-free survival with overall survival result
    Meeting Abstract

    Smyth, L. M.; Iyengar, N. M.; Chandarlapaty, S.; Sugarman, S.; Comen, E. A.; Drullinsky, P.; Sklarin, N. T.; Traina, T. A.; Troso-Sandoval, T. A.; Patil, S.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase I study of LJM716, BYL719, and trastuzumab in patients (pts) with HER2-amplified (HER2+) metastatic breast cancer (MBC)
    Meeting Abstract

    Shah, P. D.; Chandarlapaty, S.; Dickler, M. N.; Ulaner, G.; Zamora, S. J.; Sterlin, V.; Iasonos, A.; Coughlin, C. M.; Morozov, A.; Ero, J.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase I study of escalating doses of edatrexate in combination with paclitaxel in patients with metastatic breast cancer
    Journal Article

    D'Andrea, G.; Fennelly, D.; Norton, L.; Baselga, J.; Gilewski, T.; Hudis, C.; Moynahan, M. E.; Raptis, G.; Sklarin, N.; Surbone, A.; more...
    Clinical Cancer Research (1999)

    Fulltext@MSK | Save
  • Sequential dose-dense doxorubicin, paclitaxel, and cyclophosphamide for resectable high-risk breast cancer: Feasibility and efficacy
    Journal Article

    Hudis, C.; Seidman, A.; Baselga, J.; Raptis, G.; Lebwohl, D.; Gilewski, T.; Moynahan, M.; Sklarin, N.; Fennelly, D.; Crown, J. P. A.; more...
    Journal of Clinical Oncology (1999)

    Fulltext@MSK | Save
  • Lack of increased cardiac toxicity with sequential doxorubicin and paclitaxel
    Journal Article

    Hudis, C.; Riccio, L.; Seidman, A.; Baselga, J.; Currie, V.; Fennelly, D.; Gilewski, T.; Lebwohl, D.; Moynahan, M.; Raptis, G.; more...
    Cancer Investigation (1998)

    Fulltext@MSK | Save
  • Phase II study of semisynthetic paclitaxel in metastatic breast cancer
    Journal Article

    Hudis, C.; Riccio, L.; Holmes, F.; Seidman, A.; Baselga, J.; Currie, V.; Fennelly, D.; Gilewski, T.; Moynahan, M.; Raptis, G.; more...
    European Journal of Cancer (1997)

    Fulltext@MSK | Save
  • Event-free survival after sequential dose-dense doxorubicin (A), paclitaxel (T) and cyclophosphamide (C) in women (pts) with ≥ 4 positive (+) axillary lymph nodes (LN)
    Meeting Abstract

    Hudis, C.; Seidman, A.; Raptis, G.; Baselga, J.; Gilewski, T.; Fennelly, D.; Lebwohl, D.; Surbone, A.; Currie, V.; Moynahan, M.; more...
    Breast Cancer Research and Treatment (1996)

    Fulltext@MSK | Save
  • Sequential adjuvant therapy: The Memorial Sloan-Kettering Cancer Center experience
    Journal Article

    Hudis, C.; Seidman, A.; Raptis, G.; Fennelly, D.; Gilewski, T.; Baselga, J.; Theodoulou, M.; Sklarin, N.; Moynahan, M.; Surbone, A.; more...
    Seminars in Oncology (1996)

    Fulltext@MSK | Save
  • Phase II study of weekly intravenous recombinant humanized anti-p185(HER2) monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer
    Journal Article

    Baselga, J.; Tripathy, D.; Mendelsohn, J.; Baughman, S.; Benz, C. C.; Dantis, L.; Sklarin, N. T.; Seidman, A. D.; Hudis, C. A.; Moore, J.; more...
    Journal of Clinical Oncology (1996)

    Fulltext@MSK | Save
  • Phase I trial of sequential edatrexate (etx) followed by paclitaxel (ptx): A design based on in vitro (IV) synergy in patients with advanced breast cancer
    Meeting Abstract

    Fennelly, D.; Gilewski, T.; Hudis, C.; Seidman, A.; Raptis, G.; Baselga, J.; Sklarin, N.; Norton, L.
    Proceedings of the American Association for Cancer Research Annual Meeting (1995)

    Fulltext@MSK | Save